The U -shape relationship between free fatty acid level and adverse outcomes in coronary artery disease patients with hypertension: evidence from a large prospective cohort study

被引:0
作者
Wu, Ting-Ting [1 ,2 ,3 ]
Pan, Ying [1 ,2 ,3 ]
Zheng, Ying-Ying [1 ,2 ,3 ]
Wang, Zhi-Long [1 ,2 ,3 ]
Deng, Chang-Jiang [1 ,2 ,3 ]
Wang, Shun [1 ,2 ,3 ]
Xie, Xiang [1 ,2 ,3 ]
机构
[1] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, 137 Liyushan Rd, Urumqi 830054, Peoples R China
[2] Xinjiang Med Univ, Key Lab High Incidence Dis Res Xingjiang, Minist Educ, Urumqi, Peoples R China
[3] Xinjiang Med Univ, Key Lab Hypertens Res, 137 Liyushan Rd, Urumqi 830054, Peoples R China
基金
中国国家自然科学基金;
关键词
Free fatty acid; Adverse outcomes; Hypertension; Coronary artery disease; INSULIN-RESISTANCE; ENDOTHELIAL DYSFUNCTION; ACTIVATION; MORTALITY; SYSTEM; DEATH; RISK;
D O I
10.1186/s12944-024-02273-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Evidence is scarce on the effect of free fatty acid (FFA) level in the prognosis of coronary artery disease (CAD) patients with hypertension. This study. Methods A large prospective cohort study with a follow-up period of average 2 years was conducted at Xinjiang Medical University Affiliated First Hospital from December 2016 to October 2021. A total of 10,395 CAD participants were divided into groups based on FFA concentration and hypertension status, and then primary outcome mortality and secondary endpoint ischemic events were assessed in the different groups. Results A total of 222 all-cause mortality (ACMs), 164 cardiac mortality (CMs), 718 major adverse cardiovascular events (MACEs) and 803 major adverse cardiovascular and cerebrovascular events (MACCEs) were recorded during follow-up period. A nonlinear relationship between FFA and adverse outcomes was observed only in CAD patients with hypertension. Namely, a "U -shape" relationship between FFA levels and long-term outcomes was found in CAD patients with hypertension. Lower FFA level (< 310 <mu>mol/L), or higher FFA level (>= 580 mu mol/L) at baseline is independent risk factors for adverse outcomes. After adjustment for confounders, excess FFA increases mortality (ACM, HR = 1.957, 95%CI(1.240-3.087), P = 0.004; CM, HR = 2.704, 95%CI(1.495-4.890, P = 0.001) and MACE (HR = 1.411, 95%CI(1.077-1.848), P = 0.012), MACCE (HR = 1.299, 95%CI (1.013-1.666), P = 0.040) prevalence. Low levels of FFA at baseline can also increase the incidence of MACE (HR = 1.567,95%CI (1.187-2.069), P = 0.002) and MACCE (HR = 1.387, 95%CI (1.070-1.798), P = 0.013). Conclusions Baseline FFA concentrations significantly associated with long-term mortality and ischemic events could be a better and novel risk biomarker for prognosis prediction in CAD patients with hypertension. Trial registration The details of the design were registered on https://www.chictr.org.cn/ (Identifier NCT05174143).
引用
收藏
页数:9
相关论文
共 44 条
[1]   Free Fatty Acid Causes Leukocyte Activation and Resultant Endothelial Dysfunction Through Enhanced Angiotensin II Production in Mononuclear and Polymorphonuclear Cells [J].
Azekoshi, Yoko ;
Yasu, Takanori ;
Watanabe, Saiko ;
Tagawa, Tatsuya ;
Abe, Satomi ;
Yamakawa, Ken ;
Uehara, Yoshinari ;
Momomura, Shinichi ;
Urata, Hidenori ;
Ueda, Shinichiro .
HYPERTENSION, 2010, 56 (01) :136-U218
[2]   Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage [J].
Bartolomaeus, Hendrik ;
Balogh, Andras ;
Yakoub, Mina ;
Homann, Susanne ;
Marko, Lajos ;
Hoeges, Sascha ;
Tsvetkov, Dmitry ;
Krannich, Alexander ;
Wundersitz, Sebastian ;
Avery, Ellen G. ;
Haase, Nadine ;
Kraeker, Kristin ;
Hering, Lydia ;
Maase, Martina ;
Kusche-Vihrog, Kristina ;
Grandoch, Maria ;
Fielitz, Jens ;
Kempa, Stefan ;
Gollasch, Maik ;
Zhumadilov, Zhaxybay ;
Kozhakhmetov, Samat ;
Kushugulova, Almagul ;
Eckardt, Kai-Uwe ;
Dechend, Ralf ;
Rump, Lars Christian ;
Forslund, Sofia K. ;
Mueller, Dominik N. ;
Stegbauer, Johannes ;
Wilck, Nicola .
CIRCULATION, 2019, 139 (11) :1407-1421
[3]   Decoding cell death signals in liver inflammation [J].
Brenner, Catherine ;
Galluzzi, Lorenzo ;
Kepp, Oliver ;
Kroemer, Guido .
JOURNAL OF HEPATOLOGY, 2013, 59 (03) :583-594
[4]  
Charles MA, 2001, AM J EPIDEMIOL, V153, P292, DOI 10.1093/aje/153.3.292
[5]   Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited [J].
da Silva, Alexandre A. ;
do Carmo, Jussara M. ;
Li, Xuan ;
Wang, Zhen ;
Mouton, Alan J. ;
Hall, John E. .
CANADIAN JOURNAL OF CARDIOLOGY, 2020, 36 (05) :671-682
[6]   PROTEIN-KINASE-C ACTIVATORS SUPPRESS STIMULATION OF CAPILLARY ENDOTHELIAL-CELL GROWTH BY ANGIOGENIC ENDOTHELIAL MITOGENS [J].
DOCTROW, SR ;
FOLKMAN, J .
JOURNAL OF CELL BIOLOGY, 1987, 104 (03) :679-687
[7]   Obesity hypertension is related more to insulin's fatty acid than glucose action [J].
Egan, BM ;
Hennes, MMI ;
Stepniakowski, KT ;
OShaughnessy, IM ;
Kissebah, AH ;
Goodfriend, TL .
HYPERTENSION, 1996, 27 (03) :723-728
[8]   Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis [J].
Ettehad, Dena ;
Emdin, Connor A. ;
Kiran, Amit ;
Anderson, Simon G. ;
Callender, Thomas ;
Emberson, Jonathan ;
Chalmers, John ;
Rodgers, Anthony ;
Rahimi, Kazem .
LANCET, 2016, 387 (10022) :957-967
[9]   High free fatty acid concentration:: an independent risk factor for hypertension in the Paris Prospective Study [J].
Fagot-Campagna, A ;
Balkau, B ;
Simon, D ;
Warnet, JM ;
Claude, JR ;
Ducimetiere, P ;
Eschwège, E .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1998, 27 (05) :808-813
[10]   INSULIN RESISTANCE, ADIPOSE-TISSUE AND CORONARY HEART-DISEASE [J].
FRAYN, KN ;
COPPACK, SW .
CLINICAL SCIENCE, 1992, 82 (01) :1-8